Medicare Enrolled

Dr. Courtney Crawford, M.D.

Retina Specialist (Ophthalmology) Physician · Burleson, TX
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
2780 SW WILSHIRE BLVD, Burleson, TX 76028
8173784777
Registered in NPPES since 2006
NPI: 1265546170 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Crawford from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Crawford? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Crawford

Dr. Courtney Crawford is a retina specialist physician in Burleson, TX, with 20 years of NPI registration. Based on federal Medicare data, Dr. Crawford performed 8,414 Medicare services in 2023. These records do not provide a deduplicated patient total.

Between the years covered by Open Payments, Dr. Crawford received a total of $306,723 from 35 pharmaceutical and/or device companies across 226 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Crawford is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years of NPI registration ▲ Top 45% volume in TX $306,723 industry payments

Medicare Practice Summary — 2023

Medicare Utilization ↗
8,414
Medicare services
Top 45% in TX for retina specialist (ophthalmology) physician
Not available
Unique patients (not deduplicated)
$51
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Eye injection (Vabysmo/faricimab)
An injection of faricimab-svoa, a medication administered in 0.1 mg doses.
5,461 $29 $74
Retinal imaging (OCT scan)
This procedure involves imaging the retina to visualize its structure. It is used to examine the back of the eye.
843 $27 $115
Eye injection for retinal disease
A procedure involving the administration of medication directly into the eye.
660 $82 $250
Office visit, established patient (10-19 min)
An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition.
658 $38 $101
Bevacizumab injection, 10 mg
Administration of a 10 mg dose of bevacizumab medication via injection.
436 $53 $150
New patient office visit, 15-29 minutes
An initial office visit for a new patient lasting 15 to 29 minutes. This code is used when the total time spent on the date of the encounter meets this duration threshold.
192 $47 $200
Amniotic membrane placement on eye surface
This procedure involves placing amniotic membrane on the surface of the eye to promote wound healing.
47 $1,014 $2,500
Retinal imaging with remote physician review
This procedure involves imaging the retina followed by a remote review of the images by a physician.
47 $11 $94
Unclassified drug
A medication that does not fit into standard HCPCS or CPT classification categories.
36 $1,764 $7,772
Vitreous removal between lens and retina
This procedure involves the removal of the vitreous fluid located between the lens and the retina of the eye.
20 $694 $2,500
Removal of retinal membrane
A surgical procedure to remove a membrane from the surface of the retina.
14 $906 $2,500
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.

Industry Payment Transparency

Open Payments through 2024 ↗
$306,723
Total received (2018-2024)
Avg $43,818/year across 7 years
Top 3% in TX for retina specialist (ophthalmology) physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
35
Companies
226
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$38,536
2023
$166,126
2022
$83,413
2021
$12,671
2020
$49
2019
$5,578
2018
$349

Payments by company (2024)

Regeneron Healthcare Solutions, Inc.
$15,060
Dutch Ophthalmic, USA
$6,104
Regeneron Pharmaceuticals, Inc.
$5,561
EyePoint Pharmaceuticals US, Inc.
$3,492
ABBVIE INC.
$3,197
Apellis Pharmaceuticals, Inc.
$2,220
Ocular Therapeutix, Inc.
$1,501
Astellas Pharma US Inc
$700
Carl Zeiss Meditec USA, Inc.
$323
Genentech USA, Inc.
$161
Alimera Sciences, Inc.
$76
Alcon Vision LLC
$70
Sandoz Inc.
$26
Biogen, Inc.
$23
Dutch Ophthalmic Research Center (International) B.V.
$21
Top 3 companies account for 69.4% of 2024 payments
All-time payments by company (2018-2024) ›
Baxter Healthcare
$154,080
Apellis Pharmaceuticals, Inc.
$46,070
Alcon Vision LLC
$28,569
Regeneron Healthcare Solutions, Inc.
$17,126
Genentech, Inc.
$11,141
Dutch Ophthalmic, USA
$10,765
Alcon Research LLC
$7,140
Regeneron Pharmaceuticals, Inc.
$5,722
Genentech USA, Inc.
$5,063
Ocular Therapeutix, Inc.
$3,721
EyePoint Pharmaceuticals US, Inc.
$3,524
Mallinckrodt Enterprises LLC
$3,513
ABBVIE INC.
$3,247
Astellas Pharma US Inc
$2,606
AbbVie Inc.
$2,093
Oculus Surgical Inc.
$975
Carl Zeiss Meditec USA, Inc.
$323
Welch Allyn
$150
Alimera Sciences, Inc.
$140
Bausch & Lomb, a division of Bausch Health US, LLC
$106
Aerie Pharmaceuticals, Inc.
$99
Allergan Inc.
$95
Novartis Pharmaceuticals Corporation
$79
Allergan, Inc.
$67
AbbVie, Inc.
$42
BioTissue Holdings, Inc.
$42
Coherus Biosciences Inc.
$42
TissueTech, Inc.
$29
Sandoz Inc.
$26
Bausch & Lomb Americas Inc.
$24
Biogen, Inc.
$23
Optos, Inc.
$23
Dutch Ophthalmic Research Center (International) B.V.
$21
Kala Pharmaceuticals, Inc.
$21
Shire North American Group Inc
$15
Top 3 companies account for 74.6% of all-time payments
Associated products mentioned in payments ›
25+ · ACTHAR · Accurus · AcrySof · Alcon · BEOVU · BYOOVIZ · Cimerli · Clareon · Columvi · Constellation · DEXTENZA · EVA · EVA Ophthalmic Surgical System · EYLEA · EYLEA AFLIBERCEPT INJECTION · EYLEA HD · EYP-1901 · Hillrom - RetinaVue 700 Imager · Humira · ILUVIEN · INVELTYS · Izervay · LUMIGAN · LenZ · Lucentis · Luxor · NGENUITY · Non-Covered Product · OZURDEX · PANORAMIC OPHTHALMOSCOPE · PROKERA · Prokera · RetinaVue Network · Rhopressa · SYFOVRE · Syfovre · VYZULTA · Vabysmo · Viscoat · XIIDRA · XIPERE · YUTIQ · combined machine
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for a retina specialist physician in Burleson?
Compare retina specialist physicians in the Burleson area by procedure volume, costs, and industry payment transparency.
Browse retina specialist physicians nearby

Geographic Context

Retina specialist physicians in nearby ZIP areas
6
County median income
$81,826
Nearest hospital to ZIP centroid (approximate)
BAYLOR SCOTT AND WHITE EMERGENCY HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES NPPES snapshot; verify current record
Medicare Enrollment PECOS PECOS snapshot
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Crawford is a mixed practice specialist, with moderate Medicare volume, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Crawford experienced with eye injection (vabysmo/faricimab)?
Based on Medicare claims data, Dr. Crawford performed 5,461 eye injection (vabysmo/faricimab) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Crawford receive payments from pharmaceutical companies?
Yes. Dr. Crawford received a total of $306,723 from 35 companies across 226 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Crawford's costs compare to other retina specialist physicians in Burleson?
Dr. Crawford's average Medicare payment per service is $51. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Crawford) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →